187 related articles for article (PubMed ID: 36204565)
1. Functional comparison of phosphomimetic S15D and T160D mutants of myosin regulatory light chain exchanged in cardiac muscle preparations of HCM and WT mice.
Kazmierczak K; Liang J; Gomez-Guevara M; Szczesna-Cordary D
Front Cardiovasc Med; 2022; 9():988066. PubMed ID: 36204565
[TBL] [Abstract][Full Text] [Related]
2. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation Mimetic of Myosin Regulatory Light Chain Mitigates Cardiomyopathy-Induced Myofilament Impairment in Mouse Models of RCM and DCM.
Kazmierczak K; Liang J; Maura LG; Scott NK; Szczesna-Cordary D
Life (Basel); 2023 Jun; 13(7):. PubMed ID: 37511838
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic basis for rescuing hypertrophic cardiomyopathy with myosin regulatory light chain phosphorylation.
Liang J; Kazmierczak K; Veerasammy M; Yadav S; Takeuchi L; Kanashiro-Takeuchi R; Szczesna-Cordary D
Cytoskeleton (Hoboken); 2024 Mar; ():. PubMed ID: 38494592
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of AAV9-S15D-RLC gene delivery in humanized MYL2 mouse model of HCM.
Yadav S; Yuan CC; Kazmierczak K; Liang J; Huang W; Takeuchi LM; Kanashiro-Takeuchi RM; Szczesna-Cordary D
J Mol Med (Berl); 2019 Jul; 97(7):1033-1047. PubMed ID: 31101927
[TBL] [Abstract][Full Text] [Related]
6. In vitro rescue study of a malignant familial hypertrophic cardiomyopathy phenotype by pseudo-phosphorylation of myosin regulatory light chain.
Muthu P; Liang J; Schmidt W; Moore JR; Szczesna-Cordary D
Arch Biochem Biophys; 2014 Jun; 552-553():29-39. PubMed ID: 24374283
[TBL] [Abstract][Full Text] [Related]
7. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
[TBL] [Abstract][Full Text] [Related]
8. Myosin regulatory light chain phosphorylation enhances cardiac β-myosin in vitro motility under load.
Karabina A; Kazmierczak K; Szczesna-Cordary D; Moore JR
Arch Biochem Biophys; 2015 Aug; 580():14-21. PubMed ID: 26116789
[TBL] [Abstract][Full Text] [Related]
9. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.
Kazmierczak K; Liang J; Yuan CC; Yadav S; Sitbon YH; Walz K; Ma W; Irving TC; Cheah JX; Gomes AV; Szczesna-Cordary D
FASEB J; 2019 Mar; 33(3):3152-3166. PubMed ID: 30365366
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyopathic mutations in essential light chain reveal mechanisms regulating the super relaxed state of myosin.
Sitbon YH; Diaz F; Kazmierczak K; Liang J; Wangpaichitr M; Szczesna-Cordary D
J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 34014247
[TBL] [Abstract][Full Text] [Related]
11. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of force-pCa relation in
Yuan CC; Kazmierczak K; Liang J; Ma W; Irving TC; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177471
[TBL] [Abstract][Full Text] [Related]
13. Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations.
Wang Y; Xu Y; Kerrick WG; Wang Y; Guzman G; Diaz-Perez Z; Szczesna-Cordary D
J Mol Biol; 2006 Aug; 361(2):286-99. PubMed ID: 16837010
[TBL] [Abstract][Full Text] [Related]
14. Molecular and Functional Effects of a Splice Site Mutation in the MYL2 Gene Associated with Cardioskeletal Myopathy and Early Cardiac Death in Infants.
Zhou Z; Huang W; Liang J; Szczesna-Cordary D
Front Physiol; 2016; 7():240. PubMed ID: 27378946
[TBL] [Abstract][Full Text] [Related]
15. Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain.
Huang W; Liang J; Yuan CC; Kazmierczak K; Zhou Z; Morales A; McBride KL; Fitzgerald-Butt SM; Hershberger RE; Szczesna-Cordary D
FEBS J; 2015 Jun; 282(12):2379-93. PubMed ID: 25825243
[TBL] [Abstract][Full Text] [Related]
16. Cross-bridge kinetics in myofibrils containing familial hypertrophic cardiomyopathy R58Q mutation in the regulatory light chain of myosin.
Mettikolla P; Calander N; Luchowski R; Gryczynski I; Gryczynski Z; Zhao J; Szczesna-Cordary D; Borejdo J
J Theor Biol; 2011 Sep; 284(1):71-81. PubMed ID: 21723297
[TBL] [Abstract][Full Text] [Related]
17. The effect of myosin RLC phosphorylation in normal and cardiomyopathic mouse hearts.
Muthu P; Kazmierczak K; Jones M; Szczesna-Cordary D
J Cell Mol Med; 2012 Apr; 16(4):911-9. PubMed ID: 21696541
[TBL] [Abstract][Full Text] [Related]
18. Impact of regulatory light chain mutation K104E on the ATPase and motor properties of cardiac myosin.
Rasicci DV; Kirkland O; Moonschi FH; Wood NB; Szczesna-Cordary D; Previs MJ; Wenk JF; Campbell KS; Yengo CM
J Gen Physiol; 2021 Jul; 153(7):. PubMed ID: 33891674
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.
Kampourakis T; Ponnam S; Irving M
J Mol Cell Cardiol; 2018 Apr; 117():72-81. PubMed ID: 29452157
[TBL] [Abstract][Full Text] [Related]
20. E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics.
Dumka D; Talent J; Akopova I; Guzman G; Szczesna-Cordary D; Borejdo J
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2098-106. PubMed ID: 16751284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
